0001864091-21-000002.txt : 20210527
0001864091-21-000002.hdr.sgml : 20210527
20210527160258
ACCESSION NUMBER: 0001864091-21-000002
CONFORMED SUBMISSION TYPE: SC 13G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20210527
DATE AS OF CHANGE: 20210527
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Athenex, Inc.
CENTRAL INDEX KEY: 0001300699
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 431985966
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-90029
FILM NUMBER: 21972561
BUSINESS ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
BUSINESS PHONE: 716-898-8625
MAIL ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
FORMER COMPANY:
FORMER CONFORMED NAME: Kinex Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20131223
FORMER COMPANY:
FORMER CONFORMED NAME: Kinex Pharmaceuticals LLC
DATE OF NAME CHANGE: 20040817
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: IP Group PLC
CENTRAL INDEX KEY: 0001864091
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FILING VALUES:
FORM TYPE: SC 13G
BUSINESS ADDRESS:
STREET 1: THE WALBROOK
STREET 2: 25 WALBROOK
CITY: LONDON
STATE: X0
ZIP: EC4N 8AF
BUSINESS PHONE: 4402074440050
MAIL ADDRESS:
STREET 1: THE WALBROOK
STREET 2: 25 WALBROOK
CITY: LONDON
STATE: X0
ZIP: EC4N 8AF
SC 13G
1
102347108_2.txt
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
(Amendment No. )*
Under the Securities Exchange Act of 1934
Athenex, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
04685N103
(CUSIP Number)
May 4, 2021
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
( ) Rule 13d-1(b)
(x) Rule 13d-1(c)
( ) Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided
in a prior cover page.
The information required in the remainder of this cover page shall
not be deemed to be "filed" for the purpose of Section 18 of the
Securities Exchange Act of 1934 ("Act") or otherwise subject to the
liabilities of that section of the Act but shall be subject to all
other provisions of the Act (however, see the Notes).
CUSIP No. 04685N103 13G Page 1 of 7 Pages
1. NAMES OF REPORTING PERSONS:
IP Group PLC
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
Not Applicable
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION
England and Wales
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
5. SOLE VOTING POWER: -0-
6. SHARED VOTING POWER: 10,254,754 (see Item 4(a))*
7. SOLE DISPOSITIVE POWER: -0-
8. SHARED DISPOSITIVE POWER: 10,254,754 (see Item 4(a))*
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
10,254,754 (see Item 4(a))*
10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (SEE INSTRUCTIONS)
Not Applicable
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
9.4% (see Item 4(b))**
12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS): HC
* This calculation is based upon (i) 9,205,672 shares of Common
Stock (as defined below) held directly by IP2IPO
(as defined below) and (ii) 1,049,082 shares of Common Stock
held directly by Touchstone (as defined below), each of
which are indirect subsidiaries of IP Group (as defined below).
** This calculation is rounded to the nearest tenth and is
based upon 109,114,367 shares of Common Stock issued and
outstanding as of May 4, 2021, an amount determined by adding
(i) 93,512,700 shares of Common Stock issued and outstanding as
of April 30, 2021, as represented in the Issuer's Form 10-Q for
the quarterly period ending March 31, 2021, plus (ii) 15,601,667
shares of Common Stock issuable issued in connection with that
certain Merger Agreement set forth in the Issuer's Form 8-K
dated May 4, 2021.
CUSIP No. 04685N103 13G Page 2 of 7 Pages
1. NAMES OF REPORTING PERSONS:
IP2IPO Portfolio L.P.
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
Not Applicable
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION:
England and Wales
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
5. SOLE VOTING POWER: -0-
6. SHARED VOTING POWER: 9,205,672
7. SOLE DISPOSITIVE POWER: -0-
8. SHARED DISPOSITIVE POWER: 9,205,672
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
9,205,672
10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (SEE INSTRUCTIONS)
Not Applicable
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): 8.4%*
12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
PN
* This calculation is rounded to the nearest tenth and is
based upon 109,114,367 shares of Common Stock issued and
outstanding as of May 4, 2021, an amount determined by adding
(i) 93,512,700 shares of Common Stock issued and outstanding as
of April 30, 2021, as represented in the Issuer's Form 10-Q for
the quarterly period ending March 31, 2021, plus (ii) 15,601,667
shares of Common Stock issuable issued in connection with that
certain Merger Agreement set forth in the Issuer's Form 8-K
dated May 4, 2021.
CUSIP No. 04685N103 13G Page 3 of 7 Pages
1. NAMES OF REPORTING PERSONS:
Touchstone Innovations Businesses LLP
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
Not Applicable
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION:
England and Wales
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
5. SOLE VOTING POWER: -0-
6. SHARED VOTING POWER: 1,049,082
7. SOLE DISPOSITIVE POWER: -0-
8. SHARED DISPOSITIVE POWER: 1,049,082
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
1,049,082
10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (SEE INSTRUCTIONS)
Not Applicable
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
1.0% (see Item 4(b))**
12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
* This calculation is rounded to the nearest tenth and is
based upon 109,114,367 shares of Common Stock issued and
outstanding as of May 4, 2021, an amount determined by adding
(i) 93,512,700 shares of Common Stock issued and outstanding as
of April 30, 2021, as represented in the Issuer's Form 10-Q for
the quarterly period ending March 31, 2021, plus (ii) 15,601,667
shares of Common Stock issuable issued in connection with that
certain Merger Agreement set forth in the Issuer's Form 8-K
dated May 4, 2021.
CUSIP No. 04685N103 13G Page 4 of 7 Pages
Item 1(a).
Name of Issuer:
Athenex, Inc., a Delaware corporation (the "Issuer").
Item 1(b).
Address of Issuer's Principal Executive Offices:
The Issuer's principal executive office is located at
1001 Main Street, Suite 600 Buffalo, NY.
Item 2(a).
Name of Person Filing:
This Schedule 13G is filed on behalf of the following persons
(collectively, the "Reporting Persons"): (i) IP Group PLC, a
public limited company incorporated in England and Wales ("IP Group");
(ii) IP2IPO Portfolio L.P., a limited partnership registered in England
and Wales ("IP2IPO") and; Touchstone Innovations Businesses LLP, a
limited liability partnership incorporated in England and Wales ("Touchstone").
Item 2(b).
Address of Principal Business Office or, if none, Residence:
The principal business office and registered address for each
of the Reporting Persons is:
he Walbrook, 25 Walbrook, London, United Kingdom EC4N 8AF.
Item 2(c).
Citizenship:
Citizenship information is set forth in Row 4 of the cover page for
each Reporting Person and is incorporated herein by reference for
each such Reporting Person.
Item 2(d).
Title of Class of Securities:
Common stock, $0.0001 par value ("Common Stock").
Item 2(e).
CUSIP Number:
04685N103
Item 3
If this statement is filed pursuant to Section 240.13d-1(b)
or 240.13d-2(b) or (c), check whether the person filing is a:
This Item 3 is not applicable.
CUSIP No. 04685N103 13G Page 5 of 7 Pages
Item 4
Ownership:
(a)-(c)
Rows 5-9 of the cover pages above are incorporated by reference herein.
These securities are directly held by IP2IPO and Touchstone, each of
which are indirect subsidiaries wholly owned by IP Group, and, therefore,
IP Group may be deemed to beneficially own all of the securities directly
held by IP2IPO and Touchstone.
Item 5.
Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
5 percent of the class of securities, check the following ( )
Item 6.
Ownership of More Than Five Percent on Behalf of Another Person.
Not applicable.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company.
The information set forth on the cover pages for IP2IPO and Touchstone
are incorporated by reference herein.
Item 8.
Identification and Classification of Members of the Group.
Not applicable.
Item 9.
Notice of Dissolution of Group.
Not applicable.
Item 10.
Certification.
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were not acquired and are not held for
the purpose of or with the effect of changing or influencing the control
of the issuer of the securities and were not acquired and are not held in
connection with or as a participant in any transaction having that purpose
or effect.
CUSIP No. 04685N103 13G Page 6 of 7 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true,
complete and correct.
Dated: May 14, 2021
IP GROUP PLC
By: /s/ Greg Smit
Name: Greg Smith
Title: CFO
IP2IPO PORTFOLIO, L.P.
By: IP2IPO Portfolio (GP) Limited, its general partner
By: /s/ Greg Smith
Name: Greg Smith
Title: CFO
TOUCHSTONE INNOVATIONS BUSINESSES LLP
By: /s/ Greg Smith
Name: Greg Smith
Title: CFO
CUSIP No. 04685N103 13G Page 7 of 7 Pages
JOINT FILING AGREEMENT
The undersigned acknowledge and agree that the foregoing statement
on Schedule 13G is filed on behalf of each of the undersigned and
that all subsequent amendments to this statement on Schedule 13G
shall be filed on behalf of each of the undersigned without the
necessity of filing additional joint acquisition statements. The
undersigned acknowledge that each shall be responsible for the timely
filing of such amendments, and for the completeness and accuracy of
the information concerning him or it contained therein, but shall not
be responsible for the completeness and accuracy of the information
concerning the others, except to the extent that he or it knows or has
reason to believe that such information is inaccurate.
DATED: May 14, 2021
IP GROUP PLC
By: /s/ Greg Smith
Name: Greg Smith
Title: CFO
IP2IPO PORTFOLIO, L.P.
By: IP2IPO Portfolio (GP) Limited, its general partner
By: /s/ Greg Smith
Name: Greg Smith
Title: CFO
TOUCHSTONE INNOVATIONS BUSINESSES LLP
By: /s/ Greg Smith
Name: Greg Smith
Title: CFO